Authors
Klempner, Mark S.Document Type
PresentationPublication Date
2014-10-30Keywords
Chemicals and DrugsPharmaceutics and Drug Design
Pharmacy and Pharmaceutical Sciences
Public Health
Translational Medical Research
Metadata
Show full item recordAbstract
Mark Klempner, MD, Executive Vice Chancellor, MassBiologics of UMass Medical School and Professor of Medicine, describes MassBiologics and their process for developing a new medicine. MassBiologics is the only non-profit, FDA-licensed manufacturer of vaccines and biologics in the United States.DOI
10.13028/jjw6-xn97Permanent Link to this Item
http://hdl.handle.net/20.500.14038/50556Rights
Copyright the Author(s)Distribution License
http://creativecommons.org/licenses/by/4.0/ae974a485f413a2113503eed53cd6c53
10.13028/jjw6-xn97